Clopidogrel for up to one year after PCI is cost-effective for people with acute coronary syndromes

2006 ◽  
Vol 10 (2) ◽  
pp. 116-118 ◽  
Author(s):  
Dominick J Angiolillo ◽  
Debbie Singh
Keyword(s):  
Acute Coronary Syndromes ◽  
Cost Effective ◽  
Coronary Syndromes ◽  
One Year

scholarly journals One‐year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry

2020 ◽  
Vol 86 (6) ◽  
pp. 1052-1061
Author(s):  
Juan Miguel Ruiz‐Nodar ◽  
María Asunción Esteve‐Pastor ◽  
Jose Miguel Rivera‐Caravaca ◽  
Miriam Sandín ◽  
Teresa Lozano ◽  
...  
Keyword(s):  
Acute Coronary Syndromes ◽  
Efficacy And Safety ◽  
Coronary Syndromes ◽  
One Year

Renal function estimation and one-year mortality in elderly patients with non-ST-segment elevation acute coronary syndromes

2014 ◽  
Vol 174 (1) ◽  
pp. 127-128 ◽  
Author(s):  
Nuccia Morici ◽  
Stefano De Servi ◽  
Anna Toso ◽  
Ernesto Murena ◽  
Paola Tamburrini ◽  
...  
Keyword(s):  
Renal Function ◽  
Elderly Patients ◽  
Acute Coronary Syndromes ◽  
Function Estimation ◽  
St Segment Elevation ◽  
St Segment ◽  
Coronary Syndromes ◽  
One Year

Association between admission white blood cell count and one-year mortality in patients with acute coronary syndromes

2003 ◽  
Vol 115 (4) ◽  
pp. 318-321 ◽  
Author(s):  
Michael H Yen ◽  
Deepak L Bhatt ◽  
Derek P Chew ◽  
Robert A Harrington ◽  
L.Kristin Newby ◽  
...  
Keyword(s):  
Blood Cell ◽  
Cell Count ◽  
White Blood Cell Count ◽  
White Blood Cell ◽  
Acute Coronary Syndromes ◽  
Blood Cell Count ◽  
Coronary Syndromes ◽  
One Year
Sign in / Sign up

Export Citation Format

Share Document